CRISPR
Trade CRISPR 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRSP
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.
CRSP Key Statistics
Stock Snapshot
As of today, CRISPR(CRSP) shares are valued at $56.89. The company's market cap stands at 5.42B, with a P/E ratio of -10.22.
On 2025-12-10, CRISPR(CRSP) stock traded between a low of $54.50 and a high of $57.26. Shares are currently priced at $56.89, which is +4.4% above the low and -0.6% below the high.
The CRISPR(CRSP)'s current trading volume is 526.54K, compared to an average daily volume of 1.98M.
In the last year, CRISPR(CRSP) shares hit a 52-week high of $78.48 and a 52-week low of $30.04.
In the last year, CRISPR(CRSP) shares hit a 52-week high of $78.48 and a 52-week low of $30.04.
CRSP News
CRISPR Therapeutics (CRSP) is back in the spotlight after Casgevy secured both FDA and EMA approvals, shifting the story from distant promise to real commercial...
